Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v9-FR Version v4-FR
Language French French
Date Updated 2020-07-31 2020-07-22
Drug Identification Number 02087286 02087286
Brand name ALKERAN ALKERAN
Common or Proper name Alkeran Injection / Melphalan Alkeran Injection / Melphalan
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients MELPHALAN BUFFER SOLUTION MELPHALAN BUFFER SOLUTION
Strength(s) 50MG 10ML 50MG 10ML
Dosage form(s) KIT POWDER FOR SOLUTION SOLUTION KIT POWDER FOR SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS INTRAVENOUS INTRA-ARTERIAL INTRA-ARTERIAL INTRAVENOUS
Packaging size 1 vial 1 vial
ATC code L01AA L01AA
ATC description ALKYLATINGAGENTS ALKYLATINGAGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2021-02-01 2021-02-01
Actual start date 2020-07-22
Estimated end date Unknown 2020-07-27
Actual end date
Shortage status Anticipated shortage Anticipated shortage
Company comments
Health Canada comments